Cargando…
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334448/ https://www.ncbi.nlm.nih.gov/pubmed/35723862 http://dx.doi.org/10.1007/s40290-022-00422-2 |
_version_ | 1784759107595534336 |
---|---|
author | Lavery, Clare Emmott, Joanne Jeck-Thole, Sabine Rouben, Pascale Usher, Dionne van der Spuij, Willemijn Woodward, Louise |
author_facet | Lavery, Clare Emmott, Joanne Jeck-Thole, Sabine Rouben, Pascale Usher, Dionne van der Spuij, Willemijn Woodward, Louise |
author_sort | Lavery, Clare |
collection | PubMed |
description | BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed standards for the PSMF and country/regional requirements vary, leaving room for interpretation. This creates complexities for MAHs in implementing and maintaining multiple PSMFs. OBJECTIVES: The approaches taken towards the creation and maintenance of PSMFs in a global environment were investigated using a survey in order to gain a better understanding of the impact of the PSMF for MAHs. METHODS: A structured benchmarking survey was conducted during September and October of 2019 and the responses were analysed. A questionnaire with open-ended questions was designed to elicit detailed information on PSMF management and provide insights into company experiences. Companies affiliated to the EU Federation of Pharmaceutical Industries and Associations (EFPIA) and industry stakeholders with experience of PSMFs were contacted ensuring a broad representation including small, medium and large pharmaceutical companies, contract organisations/consultants and research-driven and generic organisations. RESULTS: Thirty companies responded; of these, 29 provided information relating to their PSMF practices. Respondents acknowledged that the PSMF is a valuable document that has helped to create greater awareness of pharmacovigilance within companies. Complex and varying international requirements were recognised as burdensome, especially in the context of consistent development and maintenance of multiple PSMFs. The respondents indicated that companies use the EU PSMF to manage requirements in other territories. Similar areas for standardisation were identified across respondents. CONCLUSION: The survey results highlight both the value of the PSMF and the challenges in maintaining it. Building on these responses, the paper offers pragmatic solutions to the challenges faced by MAHs and proposes a continued dialogue with key stakeholders in industry and national regulatory authorities about PSMF globalisation, harmonisation and simplification of requirements. |
format | Online Article Text |
id | pubmed-9334448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93344482022-07-30 An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach Lavery, Clare Emmott, Joanne Jeck-Thole, Sabine Rouben, Pascale Usher, Dionne van der Spuij, Willemijn Woodward, Louise Pharmaceut Med Original Research Article BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed standards for the PSMF and country/regional requirements vary, leaving room for interpretation. This creates complexities for MAHs in implementing and maintaining multiple PSMFs. OBJECTIVES: The approaches taken towards the creation and maintenance of PSMFs in a global environment were investigated using a survey in order to gain a better understanding of the impact of the PSMF for MAHs. METHODS: A structured benchmarking survey was conducted during September and October of 2019 and the responses were analysed. A questionnaire with open-ended questions was designed to elicit detailed information on PSMF management and provide insights into company experiences. Companies affiliated to the EU Federation of Pharmaceutical Industries and Associations (EFPIA) and industry stakeholders with experience of PSMFs were contacted ensuring a broad representation including small, medium and large pharmaceutical companies, contract organisations/consultants and research-driven and generic organisations. RESULTS: Thirty companies responded; of these, 29 provided information relating to their PSMF practices. Respondents acknowledged that the PSMF is a valuable document that has helped to create greater awareness of pharmacovigilance within companies. Complex and varying international requirements were recognised as burdensome, especially in the context of consistent development and maintenance of multiple PSMFs. The respondents indicated that companies use the EU PSMF to manage requirements in other territories. Similar areas for standardisation were identified across respondents. CONCLUSION: The survey results highlight both the value of the PSMF and the challenges in maintaining it. Building on these responses, the paper offers pragmatic solutions to the challenges faced by MAHs and proposes a continued dialogue with key stakeholders in industry and national regulatory authorities about PSMF globalisation, harmonisation and simplification of requirements. Springer International Publishing 2022-06-20 2022 /pmc/articles/PMC9334448/ /pubmed/35723862 http://dx.doi.org/10.1007/s40290-022-00422-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Article Lavery, Clare Emmott, Joanne Jeck-Thole, Sabine Rouben, Pascale Usher, Dionne van der Spuij, Willemijn Woodward, Louise An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title | An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title_full | An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title_fullStr | An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title_full_unstemmed | An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title_short | An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach |
title_sort | industry survey on managing the pharmacovigilance system master file in a global environment: the need for a pragmatic approach |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334448/ https://www.ncbi.nlm.nih.gov/pubmed/35723862 http://dx.doi.org/10.1007/s40290-022-00422-2 |
work_keys_str_mv | AT laveryclare anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT emmottjoanne anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT jecktholesabine anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT roubenpascale anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT usherdionne anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT vanderspuijwillemijn anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT woodwardlouise anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT laveryclare industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT emmottjoanne industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT jecktholesabine industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT roubenpascale industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT usherdionne industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT vanderspuijwillemijn industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach AT woodwardlouise industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach |